REQUEST FOR THE PROPOSAL No. 03/2021-ARG – Development of formulation and manufacturing of investigational medicinal product – update of 23.02.2021

The order carried out as a part of the project titled:

– ARG: “PRE-CLINICAL AND CLINICAL DEVELOPMENT OF ARGINASE INHBITOR FOR CANCER IMMUNOTHERAPY” (POIR.01.01.01-00-0415/17)

co-financed by European Union Funds and because of the competitiveness principle.

We hereby look for Contractor ready to perform:

Development of formulation and manufacturing of investigational medicinal product (IMP) in accordance to Good Manufacturing Practice for clinical trials of phase I & II.

3_2021_Zapytanie _ENG

Appendix no_1_2_3_4

Załącznik_nr_5_Umowa o zachowaniu poufności_Appendix_no_5_CDA

On February 23, 2021, the Ordering Party has updated Appendix No. 5 in connection with the change of share capital. The deadline for submitting offers remains unchanged.

Załącznik_nr_5_Umowa o zachowaniu poufności_Appendix_no_5_CDA_aktualizacja 23.02.2021

Kinga KazimierczakREQUEST FOR THE PROPOSAL No. 03/2021-ARG – Development of formulation and manufacturing of investigational medicinal product – update of 23.02.2021